25 of the Best Oncologists Near Me

Dr. Senthil Sukumar specializes in the care of adults with non-malignant hematologic disorders. He is an Assistant Professor of Medicine - Hematology and Oncology at Baylor College of Medicine. Dr. Sukumar’s clinical interests include: benign hematology; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; atypical hemolytic uremic syndrome; thrombosis; thrombocytopenia; anemias; and bleeding and clotting disorders. His research interests include: optimizing long-term care and improving outcomes of patients with thrombotic microangiopathies. Dr. Sukumar received his medical degree from University of Missouri-Kansas City School of Medicine. He completed his residency at the University of Texas Southwestern Medical Center in Dallas and a fellowship at The Ohio State University James Comprehensive Cancer Center. He also received a Master of Science degree from The Ohio State University. Dr. Sukumar is board-certified in Hematology and Internal Medicine from American Board of Internal Medicine. He is a member of the American Society of Hematology, Hemostasis and Thrombosis Research Society, and the International Society on Thrombosis and Haemostasis. Dr. Sukumar is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Ghosal Hematodiaphyseal Dysplasia, Blood Clots, Anemia, and Splenectomy. Dr. Sukumar is currently accepting new patients.

Dr. Hu is a 2017-2021 Seattle Met Magazine Top Doctor Award winner. Her cancer research experience has helped her follow advances in oncology and apply up-to-date treatment to her patients. Dr. Hu believes each individual is unique, and is dedicated to providing personalized, patient-centered care. Her goal is to be a patient’s advocate; helping them to understand their medical conditions while providing the best available treatment to suit their needs. Dr. Hu is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Acute Erythroid Leukemia (AEL), and Thrombocytopenia. Dr. Hu is board certified in American Board Of Internal Medicine. Dr. Hu is currently accepting new patients.

Andreea Mihai Newtson, MD, a gynecologic oncologist at Endeavor Health, provides comprehensive care for patients with cancers of the female reproductive system. She specializes in diagnosing and treating conditions such as ovarian, cervical and uterine cancer. Dr. Newtson works closely with multidisciplinary teams to offer individualized treatment plans that may include surgery, chemotherapy and advanced therapies. Dr. Newtson is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, and Sertoli-Leydig Cell Tumor. Dr. Newtson is currently accepting new patients.

Born and raised in Ogden, Utah, Nathan Peterson received his medical degree from Tulane Medical School in New Orleans, LA, and an Internal Medicine residency at Florida Atlantic University in Boca Raton. He also completed a fellowship in Medical Oncology and Hematology in Philadelphia, Pennsylvania. He is married with five amazing children. Dr. Peterson is thrilled to be back in Utah and join Intermountain Healthcare to increase the availability of cancer and hematologic care in Utah Valley. Dr. Peterson is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Paget Disease of the Breast, Breast Cancer, and D-Plus Hemolytic Uremic Syndrome. Dr. Peterson is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Peterson is currently accepting new patients.

Francisco Garcia-Moreno is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Garcia-Moreno is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Alpha Thalassemia, Alpha Thalassemia X-Linked Intellectual Disability Syndrome, Thalassemia, and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Garcia-Moreno is currently accepting new patients.

Dr. Kristin Taylor is thrilled to have joined the team at Providence Swedish Cancer Institute in July 2025. She has been recognized several times for being in the top 10% of gynecologic oncologists nationally for patient experience. With honesty, warmth, and patience, she prioritizes making her patients feel seen and heard while encountering a challenging time in their lives. Dr. Taylor believes in taking the time to build a trusting relationship with her patients so that they can decide on a personalized treatment plan together. Offering a broad scope of practice including robotic and radical surgeries, advanced therapeutics including clinical trials, and collaboration with radiation oncologists, she ensures that her patients receive the most comprehensive and up-to-date evidence-based care. Dr. Taylor is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, and Sertoli-Leydig Cell Tumor. Dr. Taylor is board certified in American Board Of Obstetrics And Gynecology. Dr. Taylor is currently accepting new patients.

Jessica Caro is a Hematologist Oncology specialist and a Hematologist practicing medicine in Lake Success, New York. She has been practicing medicine for over 10 years. Dr. Caro is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Febrile Neutropenia, Acute Myeloid Leukemia (AML), and Virus Associated Hemophagocytic Syndrome. Dr. Caro is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Caro is currently accepting new patients.

Nolan Priedigkeit, MD, PhD is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and Instructor of Medicine at Harvard Medical School. Clinically, he specializes in breast cancer and his research aims to merge computational and genomic sciences with technology development to make an impact on how we understand and treat metastatic disease. He received dual MD/PhD degrees from the University of Pittsburgh-Carnegie Mellon University Medical Scientist Training Program where his thesis applied translational genomics to discover novel drug targets in advanced breast cancers. He completed an internal medicine residency at Brigham & Women’s Hospital, a medical oncology fellowship at Dana-Farber/Mass General Brigham, and currently leads multidisciplinary research projects at the Broad Institute of MIT & Harvard focused exclusively on breast cancer. He has been supported by awards from the National Cancer Institute, American Association for Cancer Research, Conquer Cancer Foundation of ASCO, Lubin Family Foundation, and the Susan G. Komen Foundation. He values patient-centered care with a focus on open and transparent communication, generous sharing of research data and ideas, as well as mentorship of trainees in both science and medicine. Dr. Priedigkeit is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Metastatic Brain Tumor. Dr. Priedigkeit is board certified in Internal Medicine. Dr. Priedigkeit is currently accepting new patients.

Chandra Sanwal is an Oncologist and a Hematologist practicing medicine in Corpus Christi, Texas. Dr. Sanwal is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Anemia, Febrile Neutropenia, Thrombocytopenia, and Chronic Familial Neutropenia. Dr. Sanwal is board certified in American Board Of Internal Medicine. Dr. Sanwal is currently accepting new patients.

Otis Brawley is professor of oncology at the Johns Hopkins University School of Medicine and 39th Bloomberg Distinguished Professor at Johns Hopkins. Dr. Brawley leads a broad interdisciplinary research effort of cancer health disparities at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, working to close racial, economic and social disparities in the prevention, detection and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland as the Kimmel Cancer Center’s associate director for community outreach and engagement. A former professor of oncology and hematology and deputy director for cancer control at the Winship Cancer Institute at Emory University in Atlanta, Dr. Brawley is a member of the National Academy of Medicine and recently received the Martin D. Abeloff Award for Excellence in Public Health and Cancer Control from the Maryland State Council of Cancer Control. The award, named after the director of the Kimmel Cancer Center from 1992 until his death in 2007, was established to recognize advancements made in cancer control practices that influenced the field of public health on a statewide, national or global scale. A graduate of the University of Chicago’s Pritzker School of Medicine, he completed an internal medicine residency at University Hospitals of Cleveland, Case-Western Reserve University and a fellowship in medical oncology at the National Cancer Institute. Dr. Brawley is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Triple-Negative Breast Cancer, Breast Cancer, Prostatectomy, and Colonoscopy. Dr. Brawley is board certified in American Board Of Internal Medicine. Dr. Brawley is currently accepting new patients.

Sarah Dilley is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Dilley is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, and Tubal Ligation. Dr. Dilley is board certified in American Board Of Obstetrics And Gynecology, 2019. Dr. Dilley is currently accepting new patients.

Taylor Brooks is a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. Dr. Brooks is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Follicular Lymphoma. Dr. Brooks is board certified in American Board Of Internal Medicine, 2024. Dr. Brooks is currently accepting new patients.

Kimberly Esham, MD, is a board-certified hematologist and medical oncologist who specializes in benign and malignant hematology. She treats conditions such as anemia, bleeding and clotting disorders, sickle cell disease, leukemia, lymphoma and myeloma. Dr. Esham also specializes in the diagnosis and treatment of cancer, melanoma and sarcoma.When not at work, Dr. Esham enjoys experimenting with new recipes, hiking, reading and spending time with her family. Dr. Esham can often be found exploring the outdoors of the Pacific Northwest with her family. Dr. Esham is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Anemia, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Congenital Hemolytic Anemia, and Bone Marrow Aspiration. Dr. Esham is board certified in American Board Of Internal Medicine, Subspecialty In Hematology and American Board Of Internal Medicine, Subspecialty In Medical Oncology. Dr. Esham is currently accepting new patients.

I enjoy watching soccer - especially as a Real Madrid fan - and staying active through playing tennis. Dr. Samhouri is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Plasmacytoma, Burkitt Lymphoma, Non-Hodgkin Lymphoma, Orchiectomy, and Bone Marrow Aspiration. Dr. Samhouri is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Samhouri is currently accepting new patients.

Kathleen Mahoney is an Oncologist practicing medicine in Boston, Massachusetts. She has been practicing medicine for over 18 years. Dr. Mahoney is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), and Urothelial Cancer. Dr. Mahoney is board certified in American Board Of Internal Medicine. Dr. Mahoney is currently accepting new patients.

Shiva Kumar R. Mukkamalla, MD, MPH, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center - Punxsutawney Area Hospital and IRMC Cancer Center in Partnership with UPMC Hillman Cancer Center. Dr. Mukkamalla completed his medical degree at Osmania Medical College, residency at Queens Hospital Center, and fellowship at Roger Williams Medical Center. Dr. Mukkamalla is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Lynch Syndrome, Follicular Lymphoma, Breast Cancer, and Idiopathic Neutropenia. Dr. Mukkamalla is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Mukkamalla is currently accepting new patients.

Malcolm Ross is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Ross is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Pelvic Congestion Syndrome, and Ovarian Cancer. Dr. Ross is currently accepting new patients.

Anthony B. Costales, M.D. is an Assistant Professor in the Department of Gynecologic Oncology. He graduated residency in Obstetrics and Gynecology from the McGovern Medical School at UTHealth. He then completed his fellowship in Gynecologic Oncology at the Cleveland Clinic Foundation.Dr. Costales provides both medical and surgical care to women with gynecologic cancers. He performs minimally invasive surgery, both robotic and laparoscopic surgery, for appropriate patients with uterine and early-stage ovarian cancers. Dr. Costales also has a special interest in the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancers.Along with providing excellent care to his patients, Dr. Costales’ primary research interests include surgical clinical trials to optimize outcomes in gynecologic cancer patients. Specifically, he is pursuing study in the advancement of the role of minimally invasive surgery in gynecologic oncology, as well as the use of HIPEC in advanced and recurrent ovarian cancers. Dr. Costales believes in the early adoption of technology to improve outcomes in his patients. He has authored and co-authored numerous articles in peer-reviewed journals on these and other subjects.With his free time, Dr. Costales enjoys playing all sports, in particular soccer, working out at his CrossFit gym, traveling around the world with his family, and going to the dog park with his American Bulldog-Pitbull mix named Jorge. Dr. Costales is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Hysterectomy, and Oophorectomy. Dr. Costales is board certified in Texas Medical LicenseBoard Eligible In Obstetrics & GynecologyAmerican Board Of Obstetrics & GynecologyBoard Eligible In Gynecologic OncologyAmerican Board Of Obstetrics And Gynecology. Dr. Costales is currently accepting new patients.

Yen Cao, MD, is a fellowship-trained hematologist and medicaloncologist. She has a research background in Phase I trials andgenitourinary oncology, and a clinical interest in genitourinaryoncology and classical hematology.Dr. Cao’s approach to care is founded on compassion, empathyand commitment to her patients. Through her education andresearch, she strives to provide the highest standard of care,staying abreast of the latest advancements in the field. Shefosters open and honest communication to inform patients andalign treatments with their wellness goals. Dr. Cao believes inworking closely with patients, their families and a multidisciplinaryteam to develop comprehensive and personalized approaches topatient care.Dr. Cao is a member of the American Society of ClinicalOncology, American Society of Hematology and American Collegeof Physicians.Away from work, Dr. Cao enjoys spending time with her husbandand two young children, hiking, tennis, ultimate Frisbee, travelingand cooking. Dr. Cao is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Thrombocytopenia, Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), and Hemangioma Thrombocytopenia Syndrome. Dr. Cao is board certified in Internal Medicine, American Board Of Internal Medicine and Board Eligible In Hematology & Oncology, American Board Of Internal Medicine. Dr. Cao is currently accepting new patients.

Shanker Polsani, M.D., earned his medical degree from Kakatiya Medical College in India. He completed his residency at Louis A. Weiss Memorial Hospital followed by fellowship in Medical Oncology and Hematology at Brody School of Medicine at East Carolina University. He is board certified in Internal Medicine, Medical Oncology and Hematology.Prior to joining Piedmont, Dr. Polsani was Chief Fellow of Hematology and Medical Oncology at Brody School of Medicine and has worked as an Assistant Professor in the Section of Hospital Medicine at Wake Forest Baptist Medical Center in Winston Salem, NC.Dr. Polsani specializes in Medical Oncology and Hematology. Dr. Polsani has a special interest in GI, Thoracic Oncology and Classical Hematology.In his spare time, Dr. Polsani enjoys spending time with his family and friends. He enjoys playing tennis. Dr. Polsani is accepting new patients and welcomes most major insurance plans. Dr. Polsani is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Anemia, Thrombocytopenia, and Febrile Neutropenia. Dr. Polsani is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine. Dr. Polsani is currently accepting new patients.

Dr. Katherine Fuh is a gynecologic oncologist who specializes in diagnosing and managing cancers of the female reproductive system, including advanced ovarian and uterine cancers. Her expertise includes chemotherapy, targeted therapy and immunotherapy. Fuh earned her medical degree at Georgetown University School of Medicine. She completed a residency in obstetrics and gynecology at Stanford University, where she also earned a doctorate in cancer biology. She completed a fellowship in gynecologic oncology through a joint program of UCSF and Stanford Medicine. As a physician-scientist, Fuh studies how to improve outcomes for patients with ovarian or uterine cancer. She is nationally known for her use of molecular biomarkers (measurable biological indicators of disease) to guide and personalize therapy. Her laboratory focuses on identifying biomarkers associated with treatment resistance in patients with ovarian cancer and developing targeted therapies to overcome the resistance. She has been involved in numerous clinical trials (studies that use human volunteers to evaluate promising treatments) and is the principal investigator for one of the first clinical trials of a new drug for patients with treatment-resistant metastatic ovarian cancer. She is also the principal investigator on multiple research projects that received grants from various federal funders and foundations. She has published many scientific papers on gynecologic cancers, and her research has advanced how doctors approach treating these diseases. Prior to joining UCSF, Fuh was a faculty member at Washington University School of Medicine in St. Louis. In addition to directing translational and basic research there, she was an integral member of the division of gynecologic cancer and the cancer center. Dr. Fuh is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Cervical Cancer. Dr. Fuh is board certified in American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology and American Board Of OB/Gynecologic Oncology, Gynecologic Oncology. Dr. Fuh is currently accepting new patients.

Leisha Emens is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Emens is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Ovarian Cancer.

Neil Shah is a Hematologist Oncology provider practicing medicine in San Francisco, California. Dr. Shah is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Childhood Acute Myeloid Leukemia, and Polycythemia Vera. Dr. Shah is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Shah is currently accepting new patients.

Dr. Annunzio is an Assistant Professor of Medicine at the Medical College of Wisconsin in the Division of Hematology and Oncology. She specializes in the treatment of benign and malignant hematologic disorders. She completed her undergraduate training at University of Wisconsin - Madison. She attended medical school at Lake Erie College of Osteopathic Medicine - Seton Hill before completing her residency in Internal Medicine at the Medical College of Wisconsin. She completed her fellowship in Hematology and Medical Oncology at The Ohio State Medicine University where she served as Chief Fellow and completed her Masters in Medical Science. Dr. Annunzio is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Marginal Zone Lymphoma (MZL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Pancreatic Ductal Adenocarcinoma. Dr. Annunzio is board certified in Internal Medicine. Dr. Annunzio is currently accepting new patients.

Dr. Evan Walker is a gastrointestinal oncologist who cares for patients with cancers of the digestive system, particularly those of the pancreas, esophagus and stomach. Walker's research focuses on developing new cancer treatments through the design and conduct of clinical trials. He also studies genetic and environmental risk factors for cancer, and he is especially interested in the relationship between the human microbiome (microorganisms living in the body) and the development of pancreatic cancer. Walker earned his medical degree at UCSF, where he also completed a residency and chief residency in internal medicine and a fellowship in hematology and oncology. Walker is a member of the American Society of Clinical Oncology (ASCO) and American Association for Cancer Research, and he has received ASCO's Conquer Cancer Young Investigator Award and Merit Award. He also has a strong interest in medical education. At UCSF, he co-directs an educational program on clinical research (studying humans to advance medical knowledge and treatments) for internal medicine residents as well as a course on narrative medicine (an approach to medicine informed by understanding patients' life stories) for medical students. Dr. Walker is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Ocular Hypertension (OHT), Pancreatic Cancer, Familial Pancreatic Cancer, and Stomach Cancer. Dr. Walker is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Walker is currently accepting new patients.